Package 71335-2619-1

{"route": ["ORAL"], "spl_id": "44846c21-7048-4c16-a86e-6bee3469a237", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["067109d0-2539-42b6-9e95-102b58ca54dc"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "35 TABLET in 1 BOTTLE (71335-2619-1)", "package_ndc": "71335-2619-1", "marketing_start_date": "20250529"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-2619-2)", "package_ndc": "71335-2619-2", "marketing_start_date": "20250529"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (71335-2619-3)", "package_ndc": "71335-2619-3", "marketing_start_date": "20250529"}], "brand_name": "Acyclovir", "product_id": "71335-2619_44846c21-7048-4c16-a86e-6bee3469a237", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71335-2619", "generic_name": "Acyclovir", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA209366", "marketing_category": "ANDA", "marketing_start_date": "20200815", "listing_expiration_date": "20261231"}